Viromed Medical says founder Perbandt family has provided EUR 16.6 million in long-term financing since 2023

Reuters2026/08/27 06:27

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Viromed issued a clarification on its financing, highlighting founder and CEO Uwe Perbandt’s family as a long-term backer.
Family funding totaled about EUR 16.6 million during 2023-2026, aimed at liquidity support, working capital, debt repayment.
Some 2025 support was non-cash, including liability assumptions and claim offsets, reflected in related-party balances in the 2025 report.
Proceeds from planned share placements by Perbandt family are expected to be lent to Viromed to bolster working capital.
Funding supported R&D continuity, including cold plasma development for pulmonary applications, amid scientific and regulatory requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viromed Medical AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2389322_de) on August 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Viromed Medical says founder Perbandt family has provided EUR 16.6 million in long-term financing since 2023

You may also like

Crypto prices